|
September 2, 2019: Dr. Satoshi Yasuda and Dr. Arzu Kalayci Discuss: AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with at |
Dr. Satoshi Yasuda and Dr. Arzu Kalayci Discuss: AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease
TBA
[ Download video ] |
|
No comments have been submitted
|